By definition, complex traits such as obesity and its comorbidities result from complex origins. At the very least these include genetic, environmental and behavioral causes and their interactions. Epidemiologicalbased studies have identified some well-known, replicated, environmental and genetic risk factors for complex diseases. However, at the population level, investigations have tended to focus on a single cause, rarely combining a multidisciplinary approach.
generations. It has recently become possible to assess epigenetic markers such as DNA methylation on a large scale, allowing population-based studies to include epigenetic modifications as biomarkers in studies of complex traits.
In this issue, Lillycrop et al. (2017) provide a link between these results. The investigators measured genome-wide DNA methylation patterns during the perinatal period (from umbilical cord blood) and assessed their association with adiposity in childhood using a cohort from the Southampton Women's Survey. They identified 93 differentially methylated regions (DMRs) associating with percent fat mass at six years of age. Interestingly, one DMR was located near the CDKN2A locus, with lower methylation of the CDKN2A DMR at birth associated with higher percent fat mass at age 4 and 6 years. Given the wellknown GWAS results pertaining to this locus, they focused follow-up analyses on this region. They replicated their results in three other cohorts including another sample of umbilical cord DNA from infants, in DNA isolated from peripheral blood samples in adolescents, and in DNA from subcutaneous adipose tissue in adults. They moved towards further understanding of their association findings by showing that methylation levels in this DMR affect the levels of expression of transcripts from this locus (ANRIL, p16 INK4a and p14 ARF ). Finally, they demonstrated effects on ANRIL and p14 ARF promoter activity and transcription factor binding in the DMR. This study's novelty is that prior to it, there was no evidence bringing together the fetal origins of adult disease hypothesis with the epigenetic regulation of transcript expression at the CDKN2A/B locus. This study broadens the cardio-metabolic impact of the CDKN2A/B locus, and in addition provides initial mechanistic evidence of how the epigenetic state in the perinatal period might affect later adiposity. The study raises many subsequent questions for future investigations including what causes differential methylation at this locus (e.g. does maternal/fetal nutrition have an effect?), when is the key timing that differential methylation occurs in fetal development in order to affect later life traits, what are the most relevant disease-related tissues impacted by the epigenetic mechanism, how does genetic variation at this locus impact these results (though the authors saw no evidence of genetic variants in the DMR affecting their results) and most importantly, how does CDNK2A/B transcript expression operate to program body fat throughout the life course?
While there will be more to add to this story, this study demonstrates the importance of using multiple approaches to generate relevant results impacting complex disease. Biomedical research needs to continue to combine fundamental approaches and findings in ways
